Lederspan (Triamcinolone Hexacetonide)

Triamcinolone Hexacetonide is a glucocorticoid used for conditions involving joint and periarticular inflammation.

• Osteoarthritis: reduces joint inflammation and pain, improving mobility.
• Rheumatoid arthritis: controls synovial inflammation and limits joint damage.
• Bursitis: alleviates inflammation of bursae, decreasing swelling and discomfort.
• Tendonitis: diminishes local swelling and pain in affected tendons.
• Synovitis: improves joint function by suppressing inflammatory synovial tissue.

• Triamcinolone Hexacetonide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction suppresses pro‑inflammatory cytokine production, inhibits phospholipase A2 activity, and reduces leukocyte migration, resulting in potent anti‑inflammatory and immunosuppressive effects at the site of injection.

Adverse reactions may occur after periarticular administration of triamcinolone hexacetonide.

Common Side Effects

• Injection‑site pain: mild to moderate discomfort at the injection area.
• Transient hyperglycemia: temporary rise in blood glucose, especially in diabetics.
• Skin atrophy: localized thinning of skin over the injection site.
• Bruising: minor subcutaneous bleeding.
• Flushing: brief redness of the skin.
• Headache: occasional mild headache.

Serious or Rare Side Effects

• Adrenal suppression: reduced endogenous cortisol production.
• Infection: increased susceptibility to local or systemic infection.
• Severe hyperglycemia: marked elevation of blood glucose requiring medical attention.
• Osteonecrosis: death of bone tissue in the treated joint.
• Allergic reaction: rash, itching, or anaphylaxis.
• Tendon rupture: rare tearing of tendons near the injection site.

Use of triamcinolone hexacetonide requires careful consideration of patient‑specific factors.

• Pregnancy: avoid unless clearly needed; discuss risks with a healthcare professional.
• Breastfeeding: caution, as the drug may pass into milk; evaluate benefit‑risk ratio.
• Diabetes: monitor blood glucose closely, as steroid may raise levels.
• Active infection: postpone injection until infection is resolved to reduce spread risk.
• Systemic corticosteroid effects: limit repeated dosing to prevent systemic side effects.

Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Triamcinolone hexacetonide can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

• Systemic glucocorticoids: additive immunosuppression and adrenal suppression.
• CYP3A4 inhibitors (e.g., ketoconazole): increase steroid exposure.
• Live vaccines: reduced vaccine efficacy and increased infection risk.
• Anticoagulants (e.g., warfarin): heightened bleeding tendency.
• Immunosuppressants (e.g., azathioprine): enhanced immunosuppression.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin): may lower steroid levels.
• Diuretics: possible electrolyte disturbances.
• Antidiabetic agents: may require dose adjustment due to steroid‑induced hyperglycemia.